The activation of BMP signaling, either by overexpression of BMP2 in vascular cells or administration of recombinant BMPs, results in endothelial dysfunction, oxidative stress and enhanced monocyte adhesiveness to the endothelium (39). Here, CLN5 is linked to endothelial dysfunction.